These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 24466275

  • 1. miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.
    Liu AM, Xu Z, Shek FH, Wong KF, Lee NP, Poon RT, Chen J, Luk JM.
    PLoS One; 2014; 9(1):e86872. PubMed ID: 24466275
    [Abstract] [Full Text] [Related]

  • 2. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
    Jia G, Wang Y, Lin C, Lai S, Dai H, Wang Z, Dai L, Su H, Song Y, Zhang N, Feng Y, Tang B.
    J Exp Clin Cancer Res; 2021 Sep 22; 40(1):299. PubMed ID: 34551796
    [Abstract] [Full Text] [Related]

  • 3. Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.
    Chen Z, Lu X, Wang Z, Jin G, Wang Q, Chen D, Chen T, Li J, Fan J, Cong W, Gao Q, He X.
    Oncotarget; 2015 Feb 10; 6(4):2538-48. PubMed ID: 25576919
    [Abstract] [Full Text] [Related]

  • 4. miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells.
    Song L, Zhang W, Chang Z, Pan Y, Zong H, Fan Q, Wang L.
    Med Sci Monit; 2017 Apr 10; 23():1741-1750. PubMed ID: 28394882
    [Abstract] [Full Text] [Related]

  • 5. Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma.
    Hung TM, Ho CM, Liu YC, Lee JL, Liao YR, Wu YM, Ho MC, Chen CH, Lai HS, Lee PH.
    PLoS One; 2014 Apr 10; 9(2):e89446. PubMed ID: 24586785
    [Abstract] [Full Text] [Related]

  • 6. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis.
    Wong CC, Au SL, Tse AP, Xu IM, Lai RK, Chiu DK, Wei LL, Fan DN, Tsang FH, Lo RC, Wong CM, Ng IO.
    PLoS One; 2014 Apr 10; 9(12):e115036. PubMed ID: 25541689
    [Abstract] [Full Text] [Related]

  • 7. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q, Tu J, Dou C, Zhang J, Yang L, Liu X, Lei K, Liu Z, Wang Y, Li L, Bao H, Wang J, Tu K.
    Mol Cancer; 2017 Dec 20; 16(1):178. PubMed ID: 29262861
    [Abstract] [Full Text] [Related]

  • 8. PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.
    Martin SP, Fako V, Dang H, Dominguez DA, Khatib S, Ma L, Wang H, Zheng W, Wang XW.
    J Exp Clin Cancer Res; 2020 Jun 03; 39(1):99. PubMed ID: 32487192
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma.
    Xu Q, Zhang M, Tu J, Pang L, Cai W, Liu X.
    Oncol Rep; 2015 Oct 03; 34(4):2054-64. PubMed ID: 26252254
    [Abstract] [Full Text] [Related]

  • 10. Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
    Weng Q, Chen M, Yang W, Li J, Fan K, Xu M, Weng W, Lv X, Fang S, Zheng L, Song J, Zhao Z, Fan X, Ji J.
    FASEB J; 2020 Apr 03; 34(4):5420-5434. PubMed ID: 32080912
    [Abstract] [Full Text] [Related]

  • 11. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
    Liu WR, Tian MX, Yang LX, Lin YL, Jin L, Ding ZB, Shen YH, Peng YF, Gao DM, Zhou J, Qiu SJ, Dai Z, He R, Fan J, Shi YH.
    Oncotarget; 2015 Jan 20; 6(2):846-61. PubMed ID: 25514599
    [Abstract] [Full Text] [Related]

  • 12. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
    Luo G, Chao YL, Tang B, Li BS, Xiao YF, Xie R, Wang SM, Wu YY, Dong H, Liu XD, Yang SM.
    Oncotarget; 2015 Nov 10; 6(35):37808-23. PubMed ID: 26498692
    [Abstract] [Full Text] [Related]

  • 13. Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis.
    Xu Q, Dou C, Liu X, Yang L, Ni C, Wang J, Guo Y, Yang W, Tong X, Huang D.
    Biomed Pharmacother; 2018 Nov 10; 107():1692-1704. PubMed ID: 30257387
    [Abstract] [Full Text] [Related]

  • 14. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Hirata H, Sugimachi K, Komatsu H, Ueda M, Masuda T, Uchi R, Sakimura S, Nambara S, Saito T, Shinden Y, Iguchi T, Eguchi H, Ito S, Terashima K, Sakamoto K, Hirakawa M, Honda H, Mimori K.
    Cancer Res; 2016 Jun 01; 76(11):3265-76. PubMed ID: 27197151
    [Abstract] [Full Text] [Related]

  • 15. Metabolic signature genes associated with susceptibility to pyruvate kinase, muscle type 2 gene ablation in cancer cells.
    Jung Y, Jang YJ, Kang MH, Park YS, Oh SJ, Lee DC, Xie Z, Yoo HS, Park KC, Yeom YI.
    Mol Cells; 2013 Apr 01; 35(4):335-41. PubMed ID: 23515579
    [Abstract] [Full Text] [Related]

  • 16. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.
    Hu W, Lu SX, Li M, Zhang C, Liu LL, Fu J, Jin JT, Luo RZ, Zhang CZ, Yun JP.
    Oncotarget; 2015 Mar 30; 6(9):6570-83. PubMed ID: 25788265
    [Abstract] [Full Text] [Related]

  • 17. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
    Fukuda S, Miyata H, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y.
    Ann Surg Oncol; 2015 Dec 30; 22 Suppl 3():S1461-8. PubMed ID: 25808097
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
    Zhu M, Li M, Wang T, Linghu E, Wu B.
    Tumour Biol; 2016 Oct 30; 37(10):13995-14008. PubMed ID: 27492460
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF, Sun JP, Hou HT, Li K, Liu X, Ge QX.
    Tumour Biol; 2016 Nov 30; 37(11):15325-15332. PubMed ID: 27704356
    [Abstract] [Full Text] [Related]

  • 20. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
    Lian J, Jing Y, Dong Q, Huan L, Chen D, Bao C, Wang Q, Zhao F, Li J, Yao M, Qin L, Liang L, He X.
    Oncotarget; 2016 Jan 19; 7(3):2672-83. PubMed ID: 26684241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.